Graph AI is in talks to raise $14 million in Series A funding. The pharmaceutical-focused AI startup plans to use the funds to expand its platform and reach. This infusion of capital signals significant investor confidence in AI's application within the drug discovery and development lifecycle.
Opening Kapyn…